InflaRx (IFRX) Return on Equity Growth (3y) (2020 - 2026)
InflaRx (IFRX) Return on Equity Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
224.00 |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
1.00 |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
0.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
InflaRx |
764.68 Mn |
764.68 Mn |
10,877.40 |
38,856.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
38,856.00 |
| Dec 31, 2025 |
40,178.00 |
| Sep 30, 2025 |
-3,458.00 |
| Jun 30, 2025 |
-1,422.00 |
| Mar 31, 2025 |
-1,350.00 |
| Dec 31, 2024 |
-1,197.00 |
| Sep 30, 2024 |
-223,443.00 |
| Jun 30, 2024 |
-201,122.00 |
| Mar 31, 2024 |
-244,404.00 |
| Dec 31, 2023 |
-317,825.00 |
| Sep 30, 2023 |
-27,145.00 |
| Jun 30, 2023 |
-23,437.00 |
| Mar 31, 2023 |
-19,409.00 |
| Dec 31, 2022 |
-22,605.00 |
| Sep 30, 2022 |
3,458.00 |
| Jun 30, 2022 |
1,422.00 |
| Mar 31, 2022 |
1,350.00 |
| Dec 31, 2021 |
1,197.00 |
| Sep 30, 2021 |
223,443.00 |
| Jun 30, 2021 |
201,121.00 |
